Analysts Back Defense, Trim Netflix and Align

Northrop Grumman earned the day's most notable upgrade. Analysts lifted it from Hold to Buy, pushing the consensus target to $629.83. That is up from $620.25 before the change. Defense spending remains strong and Northrop continues to win large government contracts.

Intuitive Surgical saw its average target price nudge higher to $480.77. The robotic surgery leader carries 26 Buy ratings and just one Sell. Analysts remain firmly in its corner ahead of earnings.

Capital One Financial also drew a fresh target lift. The consensus price climbed to $252, with 18 Buy calls behind it. Credit conditions and consumer spending data have both held up better than feared.

Netflix drew the sharpest cut. The average target fell to $88.73 from $91.13. That reversal stands out after the stock has run hard this year. Analysts still hold 34 Buy ratings but some are pulling back expectations.

Align Technology also saw its target trimmed, to $191.64. The orthodontics maker faces slow consumer demand and pricing pressure. Seven of 15 analysts rate it Hold.

Moderna bucked the biotech caution. Its consensus target climbed to $127.16, with 15 Hold and four Buy ratings. That modest improvement reflects some stabilisation after a prolonged sell-off in the mRNA space.